Notes And Other Explanatory Information [Abstract]
| Concept |
2024-01-01 to 2024-12-31 |
|---|---|
| Notes and other explanatory information [abstract] | |
| Disclosure of accounting judgements and estimates [text block] |
NOT 4
|
| Disclosure of allowance for credit losses [text block] |
Kreditrisk
|
| Disclosure of auditors' remuneration [text block] |
NOT 9
|
| Disclosure of authorisation of financial statements [text block] |
Årsredovisning och koncernredovisning för räkenskapsåret 1
|
| Disclosure of business combinations [text block] |
av förvärvade identifierbara tillgångar samt övertagna
|
| Disclosure of cash flow statement [text block] |
NOT 26
|
| Disclosure of changes in accounting policies, accounting estimates and errors [text block] |
Nya och ändrade standarder som tillämpas 2024
|
| Disclosure of collateral [text block] |
NOT 31
|
| Disclosure of debt instruments [text block] |
Finansiella skulder värderade till upplupet anskaffningsvärde
|
| Disclosure of deferred income [text block] |
NOT 27
|
| Disclosure of deferred taxes [text block] |
Koncernens outnyttjade skattemässiga underskott beräknas till 1 707 (1 370) MSEK och moderbolagets
|
| Disclosure of derivative financial instruments [text block] |
Verkligt värde
|
| Disclosure of dividends [text block] |
NOT 34
|
| Disclosure of earnings per share [text block] |
NOT 32
|
| Disclosure of effect of changes in foreign exchange rates [text block] |
NOT 13
|
| Disclosure of employee benefits [text block] |
Ersättningar
|
| Disclosure of entity's operating segments [text block] |
NOT 6
|
| Disclosure of events after reporting period [text block] |
NOT 30
|
| Disclosure of expenses [text block] |
Nyttjanderättstillgången värderas initialt till nuvärdet av de
|
| Disclosure of expenses by nature [text block] |
NOT 14
|
| Disclosure of financial risk management [text block] |
NOT 3 –
|
| Disclosure of general information about financial statements [text block] |
NOT 1
|
| Disclosure of impairment of assets [text block] |
Prövning av nedskrivningsbehov av Forsknings- och utvecklingskostnader
|
| Disclosure of income tax [text block] |
NOT 16
|
| Disclosure of information about employees [text block] |
NOT 10 –
|
| Disclosure of information about key management personnel [text block] |
NOT 11 –
|
| Disclosure of interest income [text block] |
NOT 15
|
| Disclosure of interests in other entities [text block] |
NOT 21
|
| Disclosure of lease prepayments [text block] |
NOT 22
|
| Disclosure of leases [text block] |
I tabellen nedan analyseras koncernens finansiella skulder uppdelade eſter den tid som på
|
| Disclosure of liquidity risk [text block] |
Likviditetsrisk
|
| Disclosure of market risk [text block] |
Valutarisk
|
| Disclosure of material accounting policy information [text block] |
NOT 2
|
| Disclosure of other current liabilities [text block] |
Finansiella tillgångar värderade till upplupet anskaffningsvärde
|
| Disclosure of other operating income (expense) [text block] |
NOT 7 –
|
| Disclosure of other provisions, contingent liabilities and contingent assets [text block] |
NOT 33
|
| Disclosure of property, plant and equipment [text block] |
NOT 20
|
| Disclosure of research and development expense [text block] |
NOT 17
|
| Disclosure of revenue from contracts with customers [text block] |
Försäljningsintäkter fördelar sig på typ av intäkter enligt följande:
|
| Disclosure of share capital, reserves and other equity interest [text block] |
NOT 23
|
| Disclosure of share-based payment arrangements [text block] |
NOT 12
|
| Disclosure of subordinated liabilities [text block] |
NOT 24
|
| Disclosure of trade and other receivables [text block] |
Koncernen - 2024
|